Therapeutische gebieden

Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.¹ The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.² Assays for detecting autoimmune T1D have shown high sensitivity and specificity.^3,4

Nieuwe typen griepvaccins

Nieuwe typen griepvaccins kunnen de effectiviteit van de griepprik verbeteren. De Gezondheidsraad bracht hierover eind 2024 advies uit. Welke punten hebben hierin een rol gespeeld?

Type 2 in PN herkennen

Atopic Dermatitis Control Tool (ADCT)

GO-Doctor: Play, Experience, Learn

Lukt het jou om deze klinische casussen op tijd te diagnosticeren?

Switch naar Toujeo

Download hier de verschillende switch materialen.

DERM 360°: Advancing Treatments for Chronic Itch and Pain in AD and PN

DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice

3rd of December 2024

DERM 360°

Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.

Addressing Bone Disease in Lysosomal storage diseases

The Deliver-G study

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†¹

Mucus plugs in Asthma, and the influence of Type 2 inflammation